For more information contact:
Emil Billbäck, CEO
+46 (0) 46 286 53 70
Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se
About BONESUPPORT™
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT (https://www.bonesupport.com/en-eu/cerament%e2%84%a2/). The Company is conducting several clinical studies to further demonstrate the clinical and health economic benefits that its products deliver and a Premarket approval filing with the FDA (
BONESUPPORT and CERAMENT are registered trademarks (https://www.bonesupport.com/trademarks.html) of
https://news.cision.com/bonesupport-holding-ab/r/updated-cerament-bone-void-filler--bvf--instructions-for-use-for-the-us-market,c3218411
https://mb.cision.com/Main/16090/3218411/1320779.pdf
(c) 2020 Cision. All rights reserved., source